Specnova provides two programs to ensure high-quality stability and bioavailability of nutraceutical products. The first program is LipoVantage, which utilizes double liposomal encapsulation and AG2 Shield Technology to guarantee superior bioavailability and potency. This approach encapsulates active ingredients inside two liposomal layers, offering protection from degradation in the stomach, as well as improving absorption into the bloodstream. Moreover, the protective AG2 Shield Technology ensures that the product remains stable throughout its shelf life.
The second program is TruLiposome Validation, which verifies four critical criteria for testing liposomes, including size, encapsulation efficiency, shape, and dispersion/leak protection. By performing these tests, Specnova ensures that the liposomes meet specific standards for optimal effectiveness. Specnova is the only company to offer TruLiposome Verification, which uses advanced techniques such as dynamic light scattering (DLS), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and zeta potential testing.
Both programs utilize vegan and non-GMO LipoVantage Technology, which is suitable for a variety of product applications. By employing these programs, Specnova can deliver superior quality nutraceutical products that offer targeted delivery, enhanced bioavailability, and improved effectiveness. The company’s commitment to quality and innovation makes them a leader in the field of liposomal formulations.
